Robert Bruce's top dividend stocks (April 2025) include Organon & Co. (OGN), a global healthcare company delivering health solutions through a portfolio of prescription medicines, over-the-counter products and women's health products.

Robert Bruce is a well-known figure in the investment world. He is recognized for his focus on identifying undervalued companies with strong dividend potential. His investment strategy revolves around long-term value and income generation.

Organon & Co. (OGN)

Organon delivers impactful medicines and solutions for a healthier every day. They have a portfolio of biosimilars, women's health, and established brands. Currently, the value of this holding in Robert Bruce's portfolio sits at $440.86K. Investors can note the company's TTM dividend rate of $1.12 and a dividend yield of 7.72%. The discounted cash flow is $26.74

Here's an overview of Robert Bruce's trades in Organon & Co.: [STOCKCIRCLE_EMBED_PLACEHOLDER_ogn]

Pfizer Inc. (PFE)

Pfizer is one of the world's premier biopharmaceutical companies, discovering, developing, manufacturing, marketing, and distributing innovative medicines across a wide range of therapeutic areas. The company offers a diverse portfolio of products and solutions. Robert Bruce's current position in Pfizer is valued at $6.67M. The company’s dividend yield is 6.70% and the TTM dividend rate is $1.69. Analysts have set a price target of $32.0, while the discounted cash flow is valued at $64.3.

Here's an overview of Robert Bruce's trades in Pfizer Inc.: [STOCKCIRCLE_EMBED_PLACEHOLDER_pfe]

RLI Corp. (RLI)

RLI Corp. is a specialty insurance company serving niche or underserved markets. The company operates through various segments, offering a range of property and casualty coverages. Robert Bruce's portfolio currently holds $3.29M worth of RLI Corp. The dividend yield clocks in at 6.28%, accompanied by a TTM dividend rate of $5.02, with a discounted cash flow of $9.5.

Here's an overview of Robert Bruce's trades in RLI Corp.: [STOCKCIRCLE_EMBED_PLACEHOLDER_rli]

Viatris Inc (VTRS)

Viatris is a global healthcare company that offers a diverse portfolio of branded, generic, and biosimilar products. Their mission is to empower people worldwide to live healthier at every stage of life. This position currently makes up $501.2K of Robert Bruce's portfolio. The company's TTM dividend rate is $0.48, offering a dividend yield of 5.53%. The discounted cash flow is $34.51

Here's an overview of Robert Bruce's trades in Viatris Inc: [STOCKCIRCLE_EMBED_PLACEHOLDER_vtrs]

Avista Corp. (AVA)

Avista Corp. is an energy company involved in the production, transmission, and distribution of energy. They provide electricity and natural gas to customers across several states. The current value of Robert Bruce's holding in Avista Corp is $8.52M. Avista Corp. has a dividend yield of 4.67% and a TTM dividend rate of $1.92. An analyst price target has been set at $40.0, however, the discounted cash flow is -$37.37.

Here's an overview of Robert Bruce's trades in Avista Corp.: [STOCKCIRCLE_EMBED_PLACEHOLDER_ava]